La Jolla Pharmaceutical Company (LJPC) Social Stream
LA JOLLA PHARMACEUTICAL CO (LJPC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LJPC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-05-16 | 1 | $4 | $4 | $4 | $6.17 | -35.17% |
2022-07-13 | 1 | $6.23 | $6.23 | $6.23 | $6.17 | 0.97% |
Price Target Last Issued July 13, 2022
The Trend in the Analyst Price Target
LJPC's average price target has moved down $5.71 over the prior 17 months.
Over the past 46 weeks, LJPC's average upside potential has been 5.66%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-08-28 | 2 | 4.50 | 4.50 | 4.50 | 4.37 | 2.97% |
2021-09-18 | 2 | 4.50 | 4.50 | 4.50 | 4.02 | 11.94% |
2022-03-14 | 1 | 4.00 | 4.00 | 4.00 | 3.93 | 1.78% |
2022-05-16 | 1 | 4.00 | 4.00 | 4.00 | 4.16 | -3.85% |
2022-07-13 | 1 | 6.23 | 6.23 | 6.23 | 6.17 | 0.97% |
LJPC Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 26 months, LJPC's average broker recommendation rating worsened by 1.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LJPC as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, LA JOLLA PHARMACEUTICAL CO's number of analysts covering the stock is greater than practically none of them.
- LJPC has a lower variance in analysts' estimates than nearly 100% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, LA JOLLA PHARMACEUTICAL CO's upside potential (average analyst target price relative to current price) is higher than 6.62% of them.
- LJPC has a greater average analyst price target than 13.9% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LA JOLLA PHARMACEUTICAL CO are LIFE, LCTX, and JSPR.
View All Top Stocks by Price Target
Is LJPC a Buy, Hold or Sell? See the POWR Ratings now!